ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Amundi MSCI Korea UCITS ETF Acc

Amundi MSCI Korea UCITS ETF Acc (KRW)

54.326
1.07
( 2.01% )
Actualizado: 06:33:37

Su centro para precios en tiempo real, ideas y debates en vivo

Estadísticas y detalles clave

Último Precio
54.326
Postura de Compra
54.307
Postura de Venta
54.456
Volume Operado de la Acción
1,348
54.325 Rango del Día 54.445
0.00 Rango de 52 semanas 0.00
Precio Anterior
53.256
Precio de Apertura
54.421
Última hora de negociación
06:30:29
Volumen promedio (3 m)
-
Volumen financiero
-
Precio Promedio Ponderado
-

KRW Últimas noticias

No news to show yet.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000SP
40000000SP
120000000SP
260000000SP
520000000SP
1560000000SP
2600000000SP

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
TGLTreasure Global Inc
US$ 0.7532
(297.47%)
74.25M
MFImF International Ltd
US$ 1.70
(133.58%)
22.53M
MGOLMGO Global Inc
US$ 0.922
(56.01%)
16.23M
ONCOOnconetix Inc
US$ 0.9833
(51.02%)
15.35M
CHEKCheck Cap Ltd
US$ 1.60
(38.53%)
1.8M
HWHHWH International Inc
US$ 0.4795
(-26.12%)
345.12k
RAINRain Enhancement Technologies Holdco Inc
 5.42
(-25.75%)
9.11k
IDAIT Stamp Inc
US$ 0.515
(-24.60%)
1.77M
RMBIRichmond Mutual Bancorporation Inc
US$ 11.01
(-20.73%)
3
CUBLionheart Holdings
US$ 8.01
(-20.69%)
1
TGLTreasure Global Inc
US$ 0.7532
(297.47%)
74.25M
BLRXBioLineRx Ltd
US$ 0.3378
(32.16%)
22.79M
MFImF International Ltd
US$ 1.70
(133.58%)
22.53M
MGOLMGO Global Inc
US$ 0.922
(56.01%)
16.23M
ONCOOnconetix Inc
US$ 0.9833
(51.02%)
15.35M
Bubae Bubae 5 minutos hace
Doesn't surprise me to see LovePink working the private message circuit here. That alias promoted with a full blown dossier in 2021 with Ethema Health while Etehema Health ran to a penny and was dumping 1.3 million shares over the course of three quarters into the trips. Afterwards, LovePink checked
GRST
work-n-hard work-n-hard 5 minutos hace
FFIE: Not at the moment. Had to leave but didn't trust it enough to leave it unattended. Seems a burst like that, at the close, is often big dogs wanting to cash out.
FFIE
MartinLutherKing MartinLutherKing 5 minutos hace
https://synapse.patsnap.com/drug/ff6c315dbe7742168e9a42d545cbb7e4
RNAZ
JFBroderick JFBroderick 5 minutos hace
Let's goooood!  With multiple catalysts on the horizon in Q1, this thing is beyond primed for a run!
ASII
TheRealMrPirate TheRealMrPirate 5 minutos hace
There's no way a $40M facility would sell for $4.34M if there were other options,
Formerly #09072Q106 - FKA bioaq
There were many options, anyone could have taken this over outright on the open market for roughly $7M.
No one wanted it, I can't imag
KKR
BIOCHEMUP BIOCHEMUP 6 minutos hace
Bought Some more.
LIDR
investingnotgambling investingnotgambling 7 minutos hace
.15 would be great. What will it take to get there? I’m willing to help make it happen.

$ZHUD

🇺🇸😎🦅
ZHUD
HokieHead HokieHead 7 minutos hace
That dude is clueless lol.
TWOH
SHEEPWOLF SHEEPWOLF 7 minutos hace
$ILLR: #Triller is an AI powered creator-centric social media platform with a serious array of tools for creators, influencers, and any user looking for an entertaining time.
Get to know the #Triller universe.
https://youtu.be/zVkE9IApYW0
ILLR
MartinLutherKing MartinLutherKing 8 minutos hace
https://ir.transcodetherapeutics.com/news-releases/news-release-details/transcode-therapeutics-and-brain-biotech-join-forces-develop
RNAZ
nagoya1 nagoya1 8 minutos hace
Can u take that trainwreck attitude elsewhere.
Fnma
FNMA
SHEEPWOLF SHEEPWOLF 8 minutos hace
$ILLR: #Triller is an AI powered creator-centric social media platform with a serious array of tools for creators, influencers, and any user looking for an entertaining time.
Get to know the #Triller universe.
https://youtu.be/zVkE9IApYW0
ILLR
LTListener LTListener 8 minutos hace
"progress behind the scenes isn't halted"

They just need to get filings done which was supposedly well underway until this "pause" to get off this EM.

But the concern is how many opportunities to attract talent resources, collaborative resources, partnerships, position
RSPI
powerwalker powerwalker 9 minutos hace
boi, I don't believe TGD plans on Anavex building plants, hiring sales people, etc.

I think his idea is to be an IP company with strong ties to BP and in the long run, it is those ties that will protect Anavex and maximize shareholder value.
AVXL
Invest-in-America Invest-in-America 10 minutos hace
TGL: "Copilot" just admitted that Tiger Woods has NOTHING to do with Treasure Global, Inc.!!! So much for stupid "AI" search engines!!!! (So, my APOLOGIES for posting that nonsense here yesterday!!!!)

And yet TGL stock is still up by over 300% in the Pre-Market today!!!
TGL
MartinLutherKing MartinLutherKing 10 minutos hace
TTX-CRISPR, a CRISPR/Cas9-based therapy platform for the repair or elimination of cancer-causing genes inside tumor cells; and TTX-mRNA, an mRNA-based platform for the development of cancer vaccines that activate cytotoxic immune responses against tumor cells. TransCode Therapeutics, Inc. was incorp
RNAZ
MasterBlastr MasterBlastr 10 minutos hace
As far as AMC goes, no it doesn't make sense. And Homestead is a yawner.
AMC
cfoofme cfoofme 10 minutos hace
Ditto that. My basis is in the mid $2’s and last buy was $3.67 if I remember correctly.
AVXL
Vitamin310 Vitamin310 10 minutos hace

I got way too excited when I looked at my phone with one eye open this morning lol

Hope everyone has a good start to the new year!
TGLO
MartinLutherKing MartinLutherKing 11 minutos hace
TransCode Therapeutics, Inc., a ribonucleic acid (RNA) oncology company, focuses on the development and commercialization of drugs and diagnostics for treating and identifying various cancers. Its lead therapeutic candidate is TTX-MC138 that targets microRNA-10b, a master regulator of metastatic cel
RNAZ
Nrdc92 Nrdc92 11 minutos hace
It matters not, Proto, how good ultimately the science is if you have a collection of incompetents running the company. I can't comment on Yves yet, but this company otherwise is not staffed for success. That fact has proved itself over the last two decades. Yves is one change only. The rest of the
LWLG
TURCH TURCH 12 minutos hace
🤣 You are the King

Welcome 2025


Regards

Su Consulta Reciente

Delayed Upgrade Clock